1. Discovery of novel 1, 3, 5-triazine-thiazolidine-2, 4-diones as dipeptidyl peptidase-4 inhibitors with antibacterial activity targeting the S1 pocket for the treatment of type 2 diabetes. Issue 19 (28th January 2015) Authors: Srivastava, Jitendra Kumar; Dubey, Pragya; Singh, Saumya; Bhat, Hans Raj; Kumawat, Mukesh Kumar; Singh, Udaya Pratap Journal: RSC advances Issue: Volume 5:Issue 19(2015) Page Start: 14095 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacological evaluation of hybrid thiazolidin-4-one-1, 3, 5-triazines for NF-κB, biofilm and CFTR activity. Issue 108 (19th October 2015) Authors: Srivastava, Jitendra Kumar; Awatade, Nikhil T.; Bhat, Hans Raj; Kmit, Arthur; Mendes, Karina; Ramos, Margarida; Amaral, Margarida D.; Singh, Udaya Pratap Journal: RSC advances Issue: Volume 5:Issue 108(2015) Page Start: 88710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗